Skip to main content

Protein Discovery Raises $10M in VC Funding

NEW YORK (GenomeWeb News) – Protein Discovery today said that it has raised $10 million through a Series C round of equity financing.
The Knoxville, Tenn.-based firm is developing the Passport 1200 Sample Prep System for mass spectrometry applications. It said the funds raised in this round would support “market entry activities” of the Passport system.
"There's still too much 'artistry' involved in conventional methods of sample preparation for mass spectrometry," Chuck Witkowski, president and CEO of Protein Discovery, said in a statement. "By directing our efforts toward simplifying the process, we aim to allow mass spectrometry to grow steadily into exciting high-volume clinical applications.”
Santé Ventures, and Austin, Texas-based venture capital firm formed in 2006, led the Series C round. Other investors included Memphis Biomed Ventures, the Southern Appalachian Fund, and the Nashville Capital Network.
Kevin Lalande, managing director of Santé Ventures, will join Protein Discovery’s board of directors.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.